Konstantinopoulos, P. A., Costa, A. A. B. A. d., Gulhan, D., Lee, E. K., Cheng, S., Hendrickson, A. E. W., . . . Shapiro, G. I. (2021). A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer. Nature Portfolio.
Style de citation Chicago (17e éd.)Konstantinopoulos, Panagiotis A., et al. A Replication Stress Biomarker Is Associated with Response to Gemcitabine Versus Combined Gemcitabine and ATR Inhibitor Therapy in Ovarian Cancer. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Konstantinopoulos, Panagiotis A., et al. A Replication Stress Biomarker Is Associated with Response to Gemcitabine Versus Combined Gemcitabine and ATR Inhibitor Therapy in Ovarian Cancer. Nature Portfolio, 2021.